Medical Oncology Clinical Research Fellowships for 2026 – (1) Phase I, (2) Sarcoma
For a period of 12 months, suitable for a third year trainee or junior consultant
Chris O’Brien Lifehouse is an internationally recognised independent, not-for-profit cancer hospital leading the way in delivering patient-centred cancer care. We seek passionate, caring, and dedicated staff who align with our Founder’s vision of creating a collaborative environment in which, respect, discovery, empowerment, and nurture, thrive in the interests of our patients.
About the role:
Applications are invited for 2 fellowship positions in Medical Oncology commencing in February 2026, for a period of 12 months. The purpose of the positions is to enhance capacity for the conduct of clinical research at Chris O'Brien Lifehouse.
Duties will relate to patient care and clinical research
The Phase 1 fellow position will have a particular focus on phase 1 clinical trials (including dose escalation and first-in-man trials) within the Department of Medical Oncology, and gain experience in other quaternary sub-specialty clinics.
The sarcoma fellow position will have a particular focus on investigator-initiated multi-disciplinary research including registries, audits, biobanking, and clinical trials within the Sarcoma service (Medical Oncology, Radiation Oncology, Surgery); and gain experience in other quaternary sub-specialty clinics
The Fellow will also be involved in and teaching at various levels.
Your main duties will be to
See, assess, advise and determine optimal management of patients referred to the Department of Medical Oncology as either outpatients or inpatients.
Participate in the screening, consenting and recruitment of patients to clinical trials, and their ongoing management, including necessary meetings with clinical trial sponsors.
Establish, coordinate and contribute to investigator-initiated multi-disciplinary research.
Attend outpatient clinic and ward rounds and provide on-call duties as determined in conjunction with the Head of Department and Director of Physician Training, and carry out the prescription of investigational therapies under supervision.
Carry out clinical research projects.
Provide teaching to students, nurses and advanced trainees as required.
Attend and present material at hospital and scientific meetings.
Essential Criteria:
It is essential to be a Medical Practitioner and be registered, or eligible for registration, with the Medical Board of Australia. We anticipate candidates will either be in their 3rd year of advanced training in medical oncology, or have recently received their FRACP in medical oncology.
Demonstrated excellent interpersonal and communication skills.
Ability to accept responsibility and carry out specific tasks with minimal supervision but possess professional judgment to determine the need to seek advice from senior medical staff.
Extensive experience in the management and use of chemotherapy in treating patients.
Demonstrated ability and interest in undertaking clinical research.
Ability and willingness to teach at various levels, including undergraduates, post graduate oncology trainees, and nursing personnel.
Demonstrated commitment to continuing self-development and improvement, including interest in pursuing a higher degree.
Evidence of immunisations to comply with the NSW Health Occupational Assessment, Screening & Vaccination against Specified Infectious Diseases Policy for a Category A position
Benefits
Market competitive remuneration and benefits
Fitness passport for you and your family
Access to e-Learning programs
Social and wellbeing events
CBHS Corporate Health
Workplace banking benefits
Access EAP
If this role sounds interesting to you, apply online today to be a part of lasting change in cancer treatment and research.
Application closing date: Friday 6 June 2025
Enquiries to
A/Prof Peter Grimison (Director of Physician Training, Sarcoma, peter.grimison@lh.org.au)
Dr Mun Hui (Phase 1 lead, mun.hui@lh.org.au)
Culture
We are committed to providing a working environment where everyone is valued, respected, and supported to progress. Our priority is to ensure culture, policies, and processes are truly inclusive and that no one is disadvantaged because of their Indigenous identity, gender, culture, disability, LGBTIQA+ identities, family and caring responsibilities, age, or religion.